Drug Database
Back to search

Japan· JP-6151401F1033

クロラムフェニコールコハク酸エステルナトリウム

A chloramphenicol product containing クロラムフェニコールコハク酸エステルナトリウム, registered in Japan by アルフレッサファーマ, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.

On Japan’s NHI price listATC J01BA01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedクロラムフェニコールコハク酸エステルナトリウムATCJ01BA01REGISTER NO.JP-6151401F1033PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about クロラムフェニコールコハク酸エステルナトリウムAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chloramphenicol is registered in 6 of 19 countries.

Countries holding a registration under ATC J01BA01 (chloramphenicol), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 3 of them publish a price we can compare per daily dose
Search chloramphenicol products by name

Chloramphenicol · ATC J01BA01

6 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Japan
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
クロラムフェニコールコハク酸エステルナトリウム
Manufacturer
アルフレッサファーマ
Country
Japan (JP)
ATC code
J01BA01
ATC class
Chloramphenicol
Defined daily dose
3 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

571 interactions on record for chloramphenicol.

Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chloramphenicol against other medicinesHow interaction checks work

Chloramphenicol · interactions on record

571 records

  • 42 severe
  • 445 moderate
  • 23 minor
  • 61 info

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • LonafarnibA16AX20severe
  • GuanfacineC02AC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chloramphenicol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chloramphenicol products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Chloramphenicol Agepha, Halomycetin
  • Bulgaria · Хлорнитромицин
  • Germany · Chloramphenicol Smartpractice Europe, Posifenicol C
  • Denmark · Kloramfenikol ”santen”, Kloramfenikol Dak
  • Estonia · Oftan Akvakol
  • Spain · Oftalmolosa Cusí Cloramfenicol
  • Finland · Oftan Akvakol, Oftan Chlora
  • United Kingdom (Northern Ireland) · Almus Infected Eye, Almus Infected Eyes
  • Greece · Chloramphenicol (Χωρίσ Συντηρητικό) Pharmathen, Ursa-Fenol
  • Ireland · Chloromycetin Redidrops, Minims
  • Iceland · Oftan Chlora
  • Italy · Chemicetina, Flogocyn
  • Latvia · Oftan Akvakol
  • Malta · Posifenicol C
  • Netherlands · Chlooramfenicol Minims Bausch Health Ireland Limited, Chlooramfenicol Teva
  • Norway · Kloramfenikol Evolan, Kloramfenikol Evolan Pharma
  • Poland · Detreomycyna, Detreomycyna Chema-Elektromet
  • Portugal · Clorocil, Micetinoftalmina
  • Romania · Cloramfenicol Arena
  • Sweden · Kloramfenikol, Kloramfenikol Santen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f70b97b4-54f4-4222-b987-eeb5515a1a19
GET /v1/drugs/f70b97b4-54f4-4222-b987-eeb5515a1a19?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１ｇ１瓶（溶解液付）",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6151401F1033",
  "category": "注射薬",
  "price_yen": 1192,
  "generic_name": "クロラムフェニコールコハク酸エステルナトリウム",
  "product_name_jp": null,
  "therapeutic_class": "6151",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about chloramphenicol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console